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The Mediterranean dietary pattern has been associated with a decreased risk of many
degenerative diseases and cognitive function in particular; however, relevant information
from Mediterranean regions, where the prototype Mediterranean diet is typically adhered to,
have been very limited. Additionally, predefined Mediterranean diet (MeDi) scores with use
of a priori cut-offs have been used very rarely, limiting comparisons between different popu-
lations and thus external validity of the associations. Finally, associations between individual
components of MeDi (i.e., food groups, macronutrients) and particular aspects of cognitive
performance have rarely been explored. We evaluated the association of adherence to an a
priori defined Mediterranean dietary pattern and its components with dementia and specific
aspects of cognitive function in a representative population cohort in Greece.
Methods
Participants from the Hellenic Longitudinal Investigation of Ageing and Diet (HELIAD), an
on-going population-based study, exploring potential associations between diet and cogni-
tive performance in a representative sample from Greek regions, were included in this anal-
ysis. Diagnosis of dementia was made by a full clinical and neuropsychological evaluation,
while cognitive performance was assessed according to five cognitive domains (memory,
language, attention-speed, executive functioning, visuospatial perception) and a composite
cognitive score. Adherence to MeDi was evaluated by an a priori score (range 0–55),
derived from a detailed food frequency questionnaire.
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Results
Among 1,865 individuals (mean age 73±6 years, 41% male), 90 were diagnosed with
dementia and 223 with mild cognitive impairment. Each unit increase in the Mediterranean
dietary score (MedDietScore) was associated with a 10% decrease in the odds for demen-
tia. Adherence to the MeDi was also associated with better performance in memory, lan-
guage, visuospatial perception and the composite cognitive score; the associations were
strongest for memory. Fish consumption was negatively associated with dementia and cog-
nitive performance positively associated with non-refined cereal consumption.
Conclusions
Our results suggest that adherence to the MeDi is associated with better cognitive perfor-
mance and lower dementia rates in Greek elders. Thus, the MeDi in its a priori constructed
prototype form may have cognitive benefits in traditional Mediterranean populations.
Introduction
Population ageing is accelerating worldwide, mainly due to the increase in life expectancy, but
also the decrease in birth rates [1]. Although this can be seen as a successful result of the
improvements in health care as well as in public health policies, it also creates new challenges
to society and health systems, since it increases the rates of age-related degenerative condi-
tions. The progressive decline in cognitive function in the elderly is a major manifestation of
the ageing progress. When accompanied by loss of independence it affects the quality of life of
the individual but also has various societal and economic costs. Furthermore, dementia has
emerged as a major non-communicable disease in the elderly. In 2015, dementia affected
more that 47 million people worldwide and the number is expected to triple by 2050 [2].
Beyond the direct cost of dementia itself, a two and a half fold increase in overall mortality risk
has been estimated for people with dementia [3]. It should be noted, however, that studies that
have compared cohorts in the same population have found that later born populations have
lower risk of prevalent dementia, providing some indication that prevalence may be declining
[4–7].
The identification of factors that may slow down the decline in cognitive function or even
prevent dementia is crucial in terms of public health policy. Nutrition is a modifiable factor
that has been consistently associated with cognition at various levels, including intake of spe-
cific nutrients or food ingredients [8], consumption of specific foods [9] or specific dietary pat-
terns [10]. Due to the complex biological interactions between different components of a diet,
it has been proposed that the use of a whole-diet approach and the study of specific dietary pat-
terns may provide advantages in understanding the role of diet in chronic diseases, including
cognitive impairment in the elderly [11].
The MeDi pattern has been associated with a protective effect for many chronic diseases. In
the area of brain health, despite some negative studies [12–19], a positive relationship between
MeDi adherence and reduced risk for cognitive decline or dementia has been demonstrated by
most cross-sectional and prospective epidemiological studies [20–28] and some meta-analyses
[29–31]. Additionally, two clinical trials (both part of PREDIMED) with an extended period of
follow up support the association between MeDi and cognitive performance [32, 33], while a
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short duration intervention (i.e. 6 months) in a relatively small number of subjects failed to
find an association [34].
One of the methodological issues in the current literature includes the evaluation of adher-
ence to the MeDi, which may limit the generalizability of the results [35]. Specifically, some of
the scores that have been used so far are population-specific and cannot be directly compared
with scores computed in different samples. The use of specific cut-off points in the context of a
score addresses this limitation, measuring adherence to a pre-defined Mediterranean dietary
pattern [35]. Additionally, associations between individual components of the MeDi (i.e., spe-
cific food groups, macronutrients) and cognitive function have not been adequately explored.
Regarding the influence of diet patterns on cognition, many of the previous studies have
focused on dementia as the major clinical outcome, and, to a lesser extent, on detailed cogni-
tive functioning. Furthermore, some of the previous studies have either evaluated cognitive
function with a relatively limited cognitive assessment battery (instead of an extensive neuro-
psychological evaluation) [14, 16, 17, 19], that does not allow a comprehensive assessment of
cognitive functioning which may alter our ability to detect subtle associations between nutri-
tion and cognition and to explore relations with particular cognitive domains. Additionally
many of them have not explored in detail the relationship between the MeDi and particular
cognitive domains. Also, analyses in some of the previous studies were not fully adjusted for all
necessary potential confounding variables. Finally, associations between diet, particularly
adherence to the MeDi pattern, and cognitive performance have received limited attention in
Mediterranean populations. The only relevant study conducted in a Greek population was the
EPIC-Greece cohort that assessed cognitive function only through the Mini Mental State
Examination Test [14].
Our aim in undertaking the present study was to explore comprehensively the relationship
between the MeDi pattern and its components, and specific domains of cognitive functioning
in a representative Greek population of elderly adults, a population with a life-long Mediterra-
nean overall lifestyle. Adherence to MeDi was defined by an a priori,non population-specific
index, and cognitive function was assessed by a comprehensive clinical neuropsychological
evaluation of each participant, rather than a limited cognitive screening assessment.
Methods
Participants
Adults over the age of 64 years from the HELIAD study were included in the present analysis.
The study is a large-scale, multidisciplinary investigation involving the evaluation of a substan-
tial number of factors relevant to dementia. It is being conducted in Larissa and Marousi, two
cities in Greece and participants were selected through random sampling from municipality
records. Before entering the study, volunteers provided written informed consent. The study
protocol was approved by the University of Thessaly and the National and Kapodistrian Uni-
versity of Athens Ethics Committees. Qualified neurologists, trained neuropsychologists and
dieticians administered all questionnaires and conducted face-to-face interviews. Depending
on participants’ wishes, these sessions took place at day care centers for the elderly, the partici-
pants’ homes, etc. Overall, the study ascertained exhaustive information pertaining to domains
including demographics, medical history, neurological, psychiatric, and neuropsychological
assessment, anthropometry, social life, nutrition, sleep and lifestyle patterns. The full examina-
tion had a total duration of approximately two hours per participant. The caregivers assisted,
in case the interviewed individual was unable to provide all the information requested. Details
on the scope of the study, population, design, recruitment procedures and participation rates
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have been presented elsewhere [36]. Below we provide some additional details on selected
aspects of the evaluation that pertain to the particular analyses of this manuscript.
Clinical evaluation
Participants provided information regarding all previous neurological conditions, medical
problems and illnesses, current medications, hospitalizations, surgeries and injuries, including
traumatic brain injury. We also collected information regarding the medical history of the par-
ticipants’ first-degree relatives, with particular attention to neurological diseases. Changes in
performance of daily activities and self-care habits that require physical capacity and cognitive
functioning, in particular memory, comprehension, calculations and visuospatial orientation,
were measured using the Blessed Dementia Scale [37]. The participants’ ability to use the tele-
phone and transportation, medication management and handling of finances independently
was assessed using the Lawton Instrumental Activities of Daily Living scale (IADL) [38].
A structured memory complaint questionnaire was used to assess subjective memory prob-
lems and forgetfulness. Participants reporting memory impairment were further interviewed
about the onset, duration, course and extent of their symptoms. In particular, they were asked
about the approximate time their memory problems started and if someone else has also
noticed their difficulties with memory. In addition, they provided information regarding the
nature of symptom onset (abrupt versus gradual, insidious onset), the clinical course over time
(stable, continuous decline, stepwise deterioration, fluctuating cognition) and the extent of
memory difficulties (remembering things they have just heard, names of relatives, word find-
ing difficulties, outings, shopping, handling money). Finally they were asked whether the onset
of their memory complaints coincided with the occurrence of any medical, emotional or phys-
ical event or with a recent stroke, tremor or gait problems.
Participants were screened for neuropsychiatric symptoms using the 15-item version of the
Geriatric Depression Scale (GDS) [39, 40], the 7-item anxiety subscale of the hospital Hospital
Anxiety and Depression Scale [41–43], selected items from the Columbia University Scale for
Psychopathology in Alzheimer’s Disease (CUSPAD) [44] and the Neuropsychiatric Inventory
(NPI) [45].
A standardized physical examination was conducted for each participant. Neurologists car-
ried out a structured neurological examination and neurological findings were documented.
The presence and severity of parkinsonian signs and symptoms were assessed with the motor
examination section of the Unified Parkinson’s Disease Rating Scale [46]. Participants were
interviewed for past diagnosis of stroke or transient ischemic attack (TIA) or a history of neu-
rological symptoms consistent with stroke or TIA. When there was a history of stoke/TIA or
symptoms suggestive of cerebral ischemia, further information regarding the date of onset,
duration, constellation of symptoms, admission to hospital or any kind of rehabilitation treat-
ment was elicited [47]. Medical records, when available, were also reviewed to classify stoke
subtypes according to the TOAST criteria [48]. In addition, participants reporting memory
deterioration were also asked if they had a sudden loss of cognitive function around the time
they had a stroke and if they noticed a fluctuating or stepwise progression of their symptoms.
Based on information both from the medical history and the neurological examination, we cal-
culated the Hachinski Ischemia Scale score, which is a useful screening tool for vascular
dementia [49, 50]. To identify clinical features characteristic of Dementia with Lewy Bodies
(DLB) we used the Semi-quantified Clinical Fluctuating Cognition Rating Scale, which evalu-
ates fluctuations in the level of consciousness and/or cognition [51]. In addition, a structured
questionnaire was designed to determine presence of core (fluctuation of alertness/cognition,
visual hallucinations, parkinsonism), suggestive (REM sleep behavior disorder, severe
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neuroleptic sensitivity) or supportive features (repeated falls and syncope, transient alteration
of consciousness, severe autonomic dysfunction, hallucinations in other modalities, systema-
tised delusions, depression) of the revised DLB diagnostic criteria [52].
Neuropsychological evaluation and cognitive scores
Participants received a comprehensive neuropsychological assessment including all major cog-
nitive domains. Specifically, we examined the following cognitive domains: Orientation (Mini
Mental State Exam) [53], Verbal and Non-verbal Memory [Greek Verbal Learning Test [54]
[54], GVLT; including five learning trials of a 16-item shopping list of semantically related
items; this measure has strong internal reliability (Cronbach’s α = .84) and good diagnostic
utility (area under the ROC curve estimates at approximately 0.7 on three variables), Medical
College of Georgia Complex Figure Test (MCG)–immediate and delayed recall of an abstract
line drawing] [55], Language [semantic and phonological verbal fluency (categories: objects
and the letter A; this measure has good diagnostic validity in a Greek sample of healthy adults
and psychiatric and neurological patients) [56]; subtests of the Greek version of the Boston
Diagnostic Aphasia Examination short form, namely, the Boston Naming Test-short form,
and selected items from the Complex Ideational Material Subtest, to assess verbal comprehen-
sion and repetition of words and phrases (these measures have good discriminant validity)
[57]], Visuoperceptual Ability [Benton’s Judgment of Line Orientation [58, 59] abbreviated
form, we used every third item); MCG Complex Figure Test copy condition, Clock Drawing
Test [60] (this measure has good diagnostic validity)], Attention and Information Processing
Speed [Trail Making Test-Part A (TMT) (this measure had good diagnostic validity in a Greek
sample of healthy adults and neurological patients) [61]], Executive Functioning [TMT-Part B;
verbal fluency; Anomalous Sentence Repetition (created for the present investigation); Graphi-
cal Sequence Test; Motor Programming [62] (the last two based on Luria’s method); months
forwards and backwards], and a gross estimate of Intellectual level [a Greek multiple choice
vocabulary test, with good construction validity = 0.713 [63]].
The scores of each cognitive test were converted into z-scores using mean and standard
deviation values of the non-dementia group. Subsequently, z-scores of individual neuropsy-
chological tests were averaged to produce domain z-scores in memory, language, attention-
speed, executive and visual-spatial functioning. Decision on grouping of neuropsychological
tests was based on a priori neuropsychological knowledge of particular cognitive functions
that each test reflects. Furthermore, domain z-scores were averaged in order to calculate a
composite z-score.
Diagnoses
Diagnoses were reached through diagnostic consensus meetings of all the researchers and
main investigators, both neurologists and neuropsychologists, involved in the project. In par-
ticular, the diagnosis of dementia and its subtypes was based on DSM-IV-TR criteria [64] and
the designation of probable or possible AD was made according to the National Institute of
Neurological and Communicative Disorders and Stroke/Alzheimer Disease and Related Dis-
orders Association (NINCDS/ADRDA) criteria [65]. The diagnosis of vascular dementia was
based on a history or clinical evidence of stroke, the presence of a clear temporal relation
between stroke and the onset of dementia and the Hachinski Ischemia Scale score [49]. Lewy
body and frontotemporal dementias were diagnosed based respective criteria [66, 67]. Quanti-
fication of the staging of dementia was performed by means of a semi-structured interview of
the Clinical Dementia Rating Scale (CDR), which globally assesses six domains of cognitive
and functional performance [68].
Mediterranean diet and cognition
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Dietary assessment
Dietary intake was evaluated with a semi-quantitative food frequency questionnaire that has
been validated for the Greek population [69]. The questionnaire was completed by each partic-
ipant with the aid of an experienced investigator and when necessary with the aid of the care-
giver. Responses were converted to daily intakes of specific food items and were extrapolated
into macronutrient intakes. Energy intake was calculated by summing energy intake from
macronutrients and alcohol, assuming 4 kcal/g for carbohydrates and proteins, 9 kcal/g for lip-
ids and 7 kcal/g for alcohol. Dietary intake was also grouped into food groups featuring the
core foods of the Greek diet [70]. Adherence to the MeDi pattern was evaluated through the
Mediterranean Dietary Score (MedDietScore), proposed by Panagiotakos et al.[71]. The scor-
ing is based on the weekly consumption of eleven food groups and an individual score for each
component is calculated, ranging from 0–5. For the consumption of items that are presumed
to closely characterize the Mediterranean pattern (i.e. non-refined cereals, fruits, vegetables,
legumes, potatoes, fish and olive oil), individuals who reported no consumption were assigned
a score of 0, and scores of 1–5 are assigned for rare to daily consumption. For the consumption
of foods that are presumed to diverge from this diet pattern (i.e. meat and meat products, poul-
try and full-fat dairy products), participants were assigned scores on a reverse scale (i.e. from 5
when they reported no consumption to 0 when they reported almost daily consumption). For
alcohol intake, a score of 5 was assigned for consumption of less than 300 ml of alcohol/d, a
score of 0 was assigned for no consumption or for consumption of 700 ml/d and scores of 4–1
were assigned for consumption of 600–700, 500–600, 400–500 and 300–400 mL/d (100 mL
have 12 g of ethanol concentration), respectively. The total score ranged from 0 to 55, with
higher values indicating greater adherence to the Mediterranean dietary pattern. This score
aims to address one of the limitations of the Mediterranean scores, as the frequency of con-
sumption of each food group part of the score is used as cut-off with respect to the traditional
MeDi pattern (i.e. frequency of consumption is compared to predefined scores assumed to be
close or away from the MeDi pattern and not to the consumption of the specific population)
[35]. In the analyses of the present paper, the MedDietScore was used either as a continuous
variable, or as quartiles, where the first quartile (i.e. lowest adherence to the Mediterranean
Diet) served as the reference group and was compared to the other quartiles, i.e. Q2, Q3 and
Q4, with the last one indicating the greatest adherence to the Mediterranean Diet.
Other assessments
Height and weight were measured on a levelled platform scale and a wall-mounted stadi-
ometer, to the nearest 0.5 kg and 0.5 cm, respectively. Body Mass Index (BMI) was calculated
by dividing the weight in kilograms by the height in meters squared. The presence of clinical
co-morbidities was recorded, as part of the medical history, through the use of a questionnaire
containing 23 clinical conditions. Education was expressed as total years of education. ApoE
genotyping, available for 1,247 participants was performed in genomic DNA extracted from
blood buffy coat, using Qiamp DNA Blood Midi Kits (Qiagen, Venlo, Netherlands)[72]. ApoE
genotyping was expressed as a trichotomous variable (no e4 allele, one e4 allele, two e4 alleles).
Statistical analysis
Continuous variables are presented as mean values ± 1 standard deviation and categorical vari-
ables as relative (%) frequencies. Differences among groups were tested through analysis of
variance for continuous variables and Pearson’s x2 for categorical variables. The associations
between cognitive status (i.e. dementia versus no cognitive impairment; dependent variable)
and MedDietScore (independent variable) were evaluated by logistic regression analysis.
Mediterranean diet and cognition
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MedDietScore was entered into the models both as a continuous variable, as well as in categor-
ical form (comparing the first versus other quartiles). Associations between z-scores of cogni-
tive performance and MedDietScore or its components (expressed as servings of the specific
food groups per day) were examined with linear regression analyses. In all analyses age, sex,
education, number of clinical co-morbidities and energy intake were entered as potential con-
founders. In a supplementary analysis, ApoE genotype was also used as a potential confounder
in the subgroup of the sample that genotyping was available. We also performed supplemen-
tary analyses by limiting dementia cases to those with Alzheimer’s disease only.
Results
Of the 1,864 participants in the current analysis, 90 (5%) were diagnosed with dementia
(Table 1). Sixty-eight cases were diagnosed as Alzheimer’s disease related dementias and 22
cases as other dementias. Individuals with dementia were slightly older and reported fewer
total years of education than those without dementia. Additionally, individuals with dementia
had fewer clinical co-morbidities and reported lower energy intake, compared to those without
dementia. No differences were found between groups in macronutrient intake, expressed as
percentages of energy intake; participants with dementia consumed, however, less protein
(expressed as grams per day). Comparisons of participant characteristics by quartiles of Med-
DietScore revealed that participants in the fourth quartile of MedDietScore were slightly older,
had decreased BMI, were more educated and reported higher energy intake (Table 2) when
compared to the other quartile groups.
MeDi and dementia
Participants diagnosed with dementia had slightly lower total MedDietScore, compared to
individuals without dementia (31.8±4.5 versus 33.8±4.3 respectively, p<0.001). Prevalence of
dementia was lower in individuals categorized in the higher quartile of MedDietScore, com-
pared to other quartiles (Table 2). For each additional unit of MedDietScore we noted 8% less
likelihood of being in the dementia group in the fully adjusted model [odds ratio of 0.920
(0.870–0.974)] (Table 3). In the same model, the odds ratio for age was 1.165 (1.118–1.214);
thus the protective effect of approximately a two-unit increase in MedDietScore could








Age, years 72.7±6.0 78.6±5.9 73.0±6.1 <0.001
BMI, kg/m2 29.0±4.7 28.5±4.8 29.0±4.7 0.378
Waist circumference, cm 100.8±13.4 100.8±11.4 100.8±13.3 0.996
Sex, %male 40.4 45.6 40.6 0.328
Education, years 7.7±4.7 6.5±5.3 7.6±4.8 0.019
Number of clinical co-morbidities 2±2 3±2 2±2 0.020
Energy Intake, kcal/day 1,896±527 1,742±479 1,889±525 0.010
Carbohydrates, % energy 39±6 39±7 39±6 1.000
Protein
% of energy 14±3 14±3 14±3 0.377
g/day 67±20 61±20 66±20 0.008
Lipids, % of energy 47±7 47±7 47±7 0.743
Values are means ± SD or percentages
https://doi.org/10.1371/journal.pone.0182048.t001
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counterbalance the effect of one year of cognitive aging. Similarly, the odds ratio for dementia
was 65% lower for the individuals in the higher quartile of MeDi adherence, compared to
those in the lowest one, in the fully adjusted model.
Supplementary analyses
Since apoE genotype may be a significant factor in the development of dementia, as a sensitiv-
ity analysis we repeated these analyses in the subgroup where apoE genotyping was available,
Table 3. Results from logistic regression analysis that evaluated the association between the Mediterranean dietary score and dementia.
Model MedDietScore as a continuous variable Quartiles of MedDietScore
OR (95% CI) p-value OR (95% CI) p-value p for trend
Unadjusted 0.903 (0.859–0.950) <0.001 Q1: 1 (reference) 0.001
Q2: 1.040 (0.599–1.805) 0.890
Q3: 0.529 (0.279–1.000) 0.050
Q4: 0.348 (0.170–0.713) 0.004
Adjusted 1 0.909 (0.860–0.960) 0.001 Q1: 1 (reference) 0.005
Q2: 1.060 (0.594–1.894) 0.843
Q3: 0.601 (0.307–1.177) 0.138
Q4: 0.384 (0.181–0.816) 0.013
Fully adjusted 2 0.920 (0.870–0.974) 0.004 Q1: 1 (reference) 0.019
Q2: 1.175 (0.651–2.119) 0.593
Q3: 0.672 (0.340–1.329) 0.253
Q4: 0.449 (0.208–0.969) 0.041
1 age, sex, education and number of clinical co-morbidities were entered as potential confounders
2 further adjusted for energy intake
https://doi.org/10.1371/journal.pone.0182048.t003
Table 2. Demographic, anthropometric, medical characteristics, dietary intake and cognitive status of the study participants by quartiles of the
Mediterranean dietary score.
1st quartile, score: 19–31
(N = 416)
2nd quartile, score: 31–34
(N = 432)
3rd quartile, score: 34–37
(N = 470)
4th quartile, score: 37–46
(N = 485)
p-value
Age, years 73.9±5.9 73.3±6.0 72.3±6.7a 72.5±5.8a <0.001
BMI, kg/m2 29.4±5.0 29.3±5.0 28.6±4.4 28.7±4.3 0.014
Waist circumference, cm 102±14 101±14 100±13 101±13 0.343
Sex, %male 26.0 33.6 46.4 52.8 <0.001
Education, years 6.7±4.4 7.1±4.5 8.1±4.9a,b 8.7±4.9a <0.001
Number of clinical co-
morbidities
2±2 2±2 2±2 b 2±2 0.012
Energy Intake, kcal/day 1,708±501 1,869±526a 1,932±519a 2,022±507a,b,c <0.001
Carbohydrates, % energy 37±7 38±7 38±6 40±6a,b,c <0.001
Protein
% of energy 15±3 14±2 a 14±3 a 14±2a,b <0.001
g/day 63±20 66±20 67±21 a 69±19 a 0.001
Lipids, % of energy 48±7 48±7 48±7 46±6a,b,c <0.001
Dementia diagnosis, % 32 35 20 14 0.003
Values are means ± SD or percentages
a, b, c indicate statistically significant difference compared to value in the 1st, 2nd and 3rd quartiles of MedDietScore, respectively
https://doi.org/10.1371/journal.pone.0182048.t002
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by adding apoE genotype as a confounder in fully adjusted models. When MedDietScore was
expressed as a continuous variable, the odds for dementia remained significant and similar to
the total sample [0.878 (0.812–0.948), p = 0.001]. When MedDietScore was expressed in quar-
tiles, the odds for dementia in the forth quartile, compared to the first quartile, was also statisti-
cally significant in the fully adjusted model [0.292 (0.091–0.944), p = 0.040].
Because Alzheimer’s disease is by far the most common type of dementia, we recalculated
the models for the odds for Alzheimer’s disease related dementia only, removing participants
with other types of dementia from the analyses, and observed an almost identical association
[0.914 (0.855–0.977), p = 0.008], as when all dementias were included.
MeDi and cognitive performance
Total sample. With the exception of attention-speed, all other cognitive domains (mem-
ory, language, executive functioning, visuοspatial perception) and composite z-score were pos-
itively associated with the MedDietScore in adjusted models (Table 4). These associations
remained significant even after further adjustment for energy intake, with the exception of
Table 4. Results from multiple linear regression analysis that evaluated the association between the Mediterranean dietary score and z scores of
cognitive performance.
Domain/model All participants Excluding participants
diagnosed with dementia
Excluding participants
diagnosed with dementia and MCI1
beta ± SE p-value beta ± SE p-value beta ± SE p-value
Memory
Unadjusted 0.029±0.005 <0.001 0.025±0.005 <0.001 0.023±0.005 <0.001
Adjusted 0.018±0.005 <0.001 0.015±0.004 0.001 0.013±0.004 0.003
Fully adjusted 0.015±0.005 0.001 0.012±0.005 0.010 0.012±0.005 0.011
Language
Unadjusted 0.037±0.005 <0.001 0.032±0.005 <0.001 0.029±0.005 <0.001
Adjusted 0.014±0.004 <0.001 0.011±0.004 0.003 0.009±0.004 0.012
Fully adjusted 0.011±0.004 0.007 0.007±0.004 0.055 0.006±0.004 0.094
Attention—Speed
Unadjusted 0.030±0.007 <0.001 0.023±0.006 <0.001 0.019±0.006 0.003
Adjusted 0.002±0.006 0.684 -0.003±0.006 0.588 -0.055±0.005 0.355
Fully adjusted -0.003±0.006 0.579 -0.009±0.006 0.103 -0.010±0.006 0.066
Executive
Unadjusted 0.030±0.005 <0.001 0.024±0.004 <0.001 0.023±0.004 <0.001
Adjusted 0.011±0.004 0.006 0.005±0.004 0.174 0.005±0.004 0.146
Fully adjusted 0.008±0.004 0.049 0.002±0.004 0.532 0.003±0.004 0.410
Visuospatial
Unadjusted 0.036±0.005 <0.001 0.032±0.005 <0.001 0.026±0.005 <0.001
Adjusted 0.013±0.005 0.006 0.012±0.004 0.006 0.008±0.004 0.067
Fully adjusted 0.010±0.005 0.059 0.009±0.005 0.037 0.006±0.005 0.194
Composite
Unadjusted 0.035±0.005 <0.001 0.028±0.004 <0.001 0.025±0.004 <0.001
Adjusted 0.014±0.004 <0.001 0.009±0.003 0.007 0.007±0.003 0.030
Fully adjusted 0.010±0.004 0.007 0.005±0.003 0.139 0.004±0.003 0.253
Cells contain beta co-efficient ±SE values. Confounders used in adjusted model: age, sex, education, number of clinical co-morbidities. Fully adjusted
model was additionally adjusted for energy intake.
1 MCI: Mild cognitive impairment
https://doi.org/10.1371/journal.pone.0182048.t004
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visual-spatial domain, where the association was of borderline significance (p = 0.059). By
comparing beta coefficients of MedDietScore and age in the fully adjusted model for the com-
posite score (0.010 and -0.041, respectively), it could be argued that every 4-unit increase in
the MedDietScore could counterbalance the negative effect of 1 year of cognitive aging.
Excluding individuals with dementia. In order to exclude the possibility that the afore-
mentioned associations were affected by misreporting of dietary information in cognitively
impaired individuals, we repeated the regression analyses by excluding individuals diagnosed
with dementia. Z scores for memory, language, visuospatial domains and composite score
were significantly associated with total MedDietScore in adjusted models. Following adjust-
ment for energy intake, the association was attenuated for the composite score and was mar-
ginally significant for the language domain (p = 0.055), but remained significant for memory
and visuospatial domains.
Excluding individuals with dementia and MCI. In order to be even more conservative,
we repeated the analyses by further excluding individuals with mild cognitive impairment
(N = 223). In the adjusted models, significant associations were still observed between Med-
DietScore and memory, language and total composite z-score. In fully adjusted models
(including energy intake), only the relationship between memory z-score and MedDietScore
remained significant.
Cognition and individual components of MeDi
Individuals with dementia had lower fruits, vegetables and fish consumption, as compared to
individuals without dementia (Table 5). In fully adjusted models, a significant negative associ-
ation was observed between cognitive status (dementia or no dementia) and fish consumption
[odds ratio of 0.311 (0.147–0.658)]. Thus, for every serving of fish per day, a reduction in the
Table 5. Individual components of the Mediterranean dietary pattern by cognitive status and their association with cognitive status and cognitive
performance.




Non-dementia Dementia OR (95% CI) p-value beta±SE p-value
Non-refined cereals 0.8±0.8 0.7±0.7 0.902 (0.643–1.266) 0.551 0.059±0.021 0.004
Potatoes 0.2±0.2 0.2±0.2 4.171 (0.964–18.049) 0.056 0.003±0.106 0.980
Fruits 2.1±1.3 1.7±1.3* 0.874 (0.703–1.087) 0.225 0.006±0.013 0.652
Vegetables 2.0±1.0 1.7±1.0* 0.869 (0.662–1.139) 0.308 0.016±0.016 0.319
Legumes 0.5±0.3 0.5±0.3 1.054 (0.424–2.622) 0.910 -0.102±0.054 0.059
Fish 0.6±0.4 0.4±0.3* 0.311 (0.147–0.658) 0.002 0.065±0.038 0.090
Olive oil 1.4±0.5 1.4±0.5 1.692 (0.984–2.907) 0.057 -0.028±0.033 0.397
Red meats 0.8±0.5 0.7±0.5 0.969 (0.556–1.688) 0.911 0.027±0.035 0.437
Poultry 0.4±0.3 0.4±0.3 1.202 (0.508–2.847) 0.676 0.030±0.052 0.565
Full fat dairy 1.3±0.9 1.4±0.9 1.247 (0.949–1.639) 0.113 -0.024±0.018 0.193
Alcohol 0.4±0.7 0.3±0.7 0.850 (0.524–1.378) 0.509 0.023±0.026 0.360
1 values represents consumption expressed in servings/day, except olive oil (expressed as times/day)
2 Results from logistic regression with dependent variable: cognitive status (dementia, no dementia); independent variable: each specific component of
MeDi.
3 Results from linear regression with dependent variable: composite z-score of cognitive performance; independent variable: each specific component of
MeDi.
All models presented are fully adjusted (adjusted for age, sex, education, number of clinical co-morbidities, energy intake).
* Indicates statistically significant difference, compared to non-dementia group, at p<0.05.
https://doi.org/10.1371/journal.pone.0182048.t005
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risk of dementia by 68.9% was observed or, alternatively, 1 serving of fish per week was associ-
ated with a 9.8% reduction in the risk of dementia. The total composite score was positively
associated with non-refined cereal consumption (beta coefficient of 0.059±0.021) in the fully
adjusted model with beta coefficient for age of -0.042±003; hence the beneficial effect on cogni-
tive performance of an increase of non-refined cereals by a serving per day could be considered
equal, in absolute terms, with the detrimental effect of 1.4 years of cognitive aging.
Discussion
The MeDi dietary pattern has been associated with various health benefits and decreased risk
of many diseases. In this observational analysis of 1,864 elderly individuals from a Mediterra-
nean region (Greece) we found that adherence to this pattern was positively associated with a
decreased likelihood of dementia and better cognitive performance in many domains, espe-
cially memory. Furthermore, individual components of the MeDi, specifically fish and whole
cereals, were associated with better cognitive performance.
Some studies have failed to establish an association between adherence to the Mediterra-
nean diet and cognition. The absence of association in these studies could be attributed to lack
of statistical power, i.e. few new cases of diagnosed cognitive impairment at follow-up [12],
specific characteristics of the population examined, e.g. individuals with, or at risk of, cardio-
vascular disease [17] or limitations in the assessment of adherence to the Mediterranean diet
by the use of a posteriori scores [12, 14, 16, 17]. At the same time, several cohort studies, as well
as meta-analyses, have revealed a protective effect of the MeDi against cognitive decline in the
elderly [20–26, 29–31]. Our results are in line with these studies, and, in fact, extend current
knowledge by establishing a positive association between adherence to the MeDi pattern and
domain-specific cognitive performance, even in individuals without dementia. Up to date, the
few clinical trials in the area have reported inconsistent results. Two studies in the Spanish
population have provided results in favor of an association between MeDi and cognitive func-
tion [32, 33], while a 6-month intervention in the Australian population failed to establish an
association [34]. Possible explanations for the lack of an association in this study could be the
short duration of the intervention, the relatively limited number of participants, or the way
MeDi was defined (i.e. based on the Australian food and nutrient profile, rather than a more
traditional MeDi definition) resulting in smaller nutritional intervention differences between
the experimental and the control groups.
The mechanisms by which adherence to the MeDi could exert a protective effect are not
fully understood. It has been proposed that the beneficial effects on cognitive function could
be mediated through positive effects on cardiovascular risk factors [73, 74]. Furthermore cere-
brovascular mechanisms may be involved. A recent study has found that MeDi was associated
with reduced brain infarcts [75] and a lower white matter hyperintensity volume [76] in elderly
individuals. Another way by which the MeDi may confer its favorable effects in cognitive func-
tion is through its anti-oxidant capacity [77] and anti-inflammatory properties [78]. Inflam-
mation has been associated with compromised vascular health, as well as neuronal damage in
the brain, through amyloid peptides accumulation and subsequent activation of microglia and
reactive astrocytes [79]. In favor of this potential protective mechanism of MeDi, non-refined
cereals consumption, a food group with high antioxidant potential, was independently associ-
ated with cognitive performance.
Alzheimer’s disease is a neurological condition where neuro-degeneration and hippocam-
pal atrophy is most prominent, even in early phases of the disease’s development [80]. Diet
quality has been shown to be related to the volume of the hippocampus (the brain structure
that is mainly associated with learning and memory) [81]. In elderly humans, MeDi has been
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associated with reduced brain atrophy [82] and reduced amyloid peptides load in the brain
[83]. In our study, the relative risk for all dementias was identical with the relative risk for Alz-
heimer’s disease related dementia, while memory was the only cognitive domain consistently
associated with MedDietScore, in fully adjusted models and in all cognitive status groups.
Taken together, these observations and our results may indicate that the protective effect of
MeDi may be mediated by beneficial effects on neuro-degeneration.
Interactions of diet and health and the effect of diet on disease development are complex
and difficult to establish. We consistently observed a positive association between adherence
to the MeDi pattern and cognitive function, however the associations of individual compo-
nents of this pattern with cognitive function were less strong and most of them were attenu-
ated in fully adjusted models. As also noted in other studies [26], it appears that interactions of
the components of the MeDi pattern or their additive effect, and thus the overall pattern, may
be more important for health enhancement than individual food groups alone.
Regarding individual components of the MedDietScore employed in this study, fish con-
sumption was the only predictor of dementia. A substantial body of evidence exists, supporting
an association between fish consumption and dementia [84]. Additionally, non-refined cereals
were the only food group that was a significantly associated with cognitive performance. This
finding has also been reported in a large prospective study of elderly women, wherein greater
whole grain intake was not associated with cognitive trajectories, but was related to higher
average global cognition scores [85]. This association may be mediated through the antioxi-
dant potential of the specific food group or its other properties, e.g. factors that coincide with
increased fiber consumption. Alternatively, increased consumption of non-refined (versus
refined) cereals may be an indicator of an increased effort to adhere to a prudent diet.
Our study has several limitations. This is a cross-sectional analysis that cannot provide
causal relationships, only state hypotheses for future explorations. Thus, reverse causality can-
not be excluded. Another limitation is the precision in the assessment of dietary intake by a
food frequency questionnaire and the possibility that individuals with cognitive impairment
may misreport their food consumption. Precise and easily applicable methods for the dietary
assessment of such large populations, however, are scarce. Additionally, we took every precau-
tion to limit food consumption misreporting. Specifically, trained dietitians administered the
questionnaires and when precise information could not be obtained, the caregiver of the indi-
vidual assisted in the data collection. We also performed all sensitivity analyses possible in
order to exclude misreporting (i.e. excluding not only individuals without dementia, but even
those with mild cognitive impairment). Although we took under consideration many con-
founders, the influence of other confounders not assessed in this study (i.e. residual confound-
ing) cannot be entirely excluded.
At the same time, our study has many strengths. We administered a comprehensive neuro-
psychological evaluation that included both a full neuropsychological battery and a diagnosis
of cognitive impairment based on consensus of the investigators’ team, with use of standard
criteria. A major advantage of the study is the scoring system used for estimating adherence to
Medi. We used a score that is based on weighting of the selected food groups based on the fre-
quency of consumption (thresholds were chosen according to an a priori hypothesis) and
regardless of the consumption by the sample studied [35].Dietary data were also collected with
an instrument validated in the population studied. Furthermore, our sample is population rep-
resentative and includes individuals from both a rural and an urban area. In addition, we
adjusted for many potential confounders and we performed all necessary sensitivity analyses.
In conclusion, our data suggest a positive association between adherence to the MeDipat-
tern and dementia absence, as well as specific domains of cognitive performance, especially
memory, in a traditional Mediterranean population. It seems that the total dietary pattern,
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rather than individual components, confers the most beneficial effects. This may be of clinical
relevance in the setting of population-based prevention efforts as well as in clinical practice.
The completion of follow-up evaluations in HELIAD, studies with more robust design, and
especially clinical trials, should confirm these associations and elucidate the mechanisms by
which MeDi or its components exert their potential health enhancing effects on the nervous
system.
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